You are here

Article info

Article menu
Download PDFPDF
Coronary artery disease
Original research
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis

Authors

  • Jing Li Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Heyue Du Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Yang Wang Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Bert Aertgeerts Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Gordon Guyatt Department of Clinical Epidemiology and Biostatistics, and Department of Medicine, and School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada PubMed articlesGoogle scholar articles
  • Qiukui Hao Department of Clinical Epidemiology and Biostatistics, and Department of Medicine, and School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Yanjiao Shen Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Ling Li Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Na Su Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Nicolas Delvaux Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Geertruida Bekkering Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Safi U Khan Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Irbaz B Riaz Mayo Clinic Arizona and Brigham and Women hospital, Harvard Medical School, Boston, New York, USA PubMed articlesGoogle scholar articles
  • Per Olav Vandvik Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Baihai Su Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Haoming Tian Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  • Sheyu Li Department of Endocrinology and Metabolism, Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sheyu Li, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China; lisheyu{at}gmail.com
View Full Text

Citation

Li J, Du H, Wang Y, et al
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis
Heart 2022;108:1296-1302.

Publication history

  • Received November 30, 2021
  • Accepted February 10, 2022
  • First published May 4, 2022.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.